These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 15593306)
21. Purification of human prostatic-specific antigen (hPSA) from seminal plasma by immunoaffinity chromatography using a monoclonal antibody anti total PSA. Pérez L; Zulueta O; Melchor A; Hernández L; López R; Cazanave J; Béquer D Hybridoma (Larchmt); 2011 Jun; 30(3):247-51. PubMed ID: 21707359 [TBL] [Abstract][Full Text] [Related]
22. Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA. Tabarés G; Radcliffe CM; Barrabés S; Ramírez M; Aleixandre RN; Hoesel W; Dwek RA; Rudd PM; Peracaula R; de Llorens R Glycobiology; 2006 Feb; 16(2):132-45. PubMed ID: 16177264 [TBL] [Abstract][Full Text] [Related]
23. Characterization of prostate-specific antigen proteolytic activity on its major physiological substrate, the sperm motility inhibitor precursor/semenogelin I. Robert M; Gibbs BF; Jacobson E; Gagnon C Biochemistry; 1997 Apr; 36(13):3811-9. PubMed ID: 9092810 [TBL] [Abstract][Full Text] [Related]
24. Enzymatic activation of a doxorubicin-peptide prodrug by prostate-specific antigen. Denmeade SR; Nagy A; Gao J; Lilja H; Schally AV; Isaacs JT Cancer Res; 1998 Jun; 58(12):2537-40. PubMed ID: 9635575 [TBL] [Abstract][Full Text] [Related]
25. Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2. Kumar A; Mikolajczyk SD; Goel AS; Millar LS; Saedi MS Cancer Res; 1997 Aug; 57(15):3111-4. PubMed ID: 9242434 [TBL] [Abstract][Full Text] [Related]
26. Production of an anti-prostate-specific antigen single-chain antibody fragment from Pichia pastoris. Wang Y; Wang K; Jette DC; Wishart DS Protein Expr Purif; 2001 Dec; 23(3):419-25. PubMed ID: 11722178 [TBL] [Abstract][Full Text] [Related]
27. A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer. Mikolajczyk SD; Marker KM; Millar LS; Kumar A; Saedi MS; Payne JK; Evans CL; Gasior CL; Linton HJ; Carpenter P; Rittenhouse HG Cancer Res; 2001 Sep; 61(18):6958-63. PubMed ID: 11559576 [TBL] [Abstract][Full Text] [Related]
28. Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glycopeptide approach. Tajiri M; Ohyama C; Wada Y Glycobiology; 2008 Jan; 18(1):2-8. PubMed ID: 17956937 [TBL] [Abstract][Full Text] [Related]
29. Presence and enzymatic activity of prostate-specific antigen in archival prostate cancer samples. Vukmirovic-Popovic S; Escott NG; Duivenvoorden WC Oncol Rep; 2008 Oct; 20(4):897-903. PubMed ID: 18813833 [TBL] [Abstract][Full Text] [Related]
30. Structural model of human PSA: a target for prostate cancer therapy. Hassan MI; Kumar V; Singh TP; Yadav S Chem Biol Drug Des; 2007 Sep; 70(3):261-7. PubMed ID: 17718721 [TBL] [Abstract][Full Text] [Related]
31. A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols. Lundberg K; Roos AK; Pavlenko M; Leder C; Wehrum D; Guevara-Patiño J; Andersen RS; Pisa P Vaccine; 2009 Mar; 27(10):1557-65. PubMed ID: 19171173 [TBL] [Abstract][Full Text] [Related]
32. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy. Ohyama C; Hosono M; Nitta K; Oh-eda M; Yoshikawa K; Habuchi T; Arai Y; Fukuda M Glycobiology; 2004 Aug; 14(8):671-9. PubMed ID: 15044396 [TBL] [Abstract][Full Text] [Related]
33. Development of novel peptide ligands modulating the enzyme activity of prostate-specific antigen. Leinonen J; Wu P; Koivunen E; Närvänen A; Stenman UH Scand J Clin Lab Invest Suppl; 2000; 233():59-64. PubMed ID: 11317943 [TBL] [Abstract][Full Text] [Related]
34. One-step immunostrip test for the simultaneous detection of free and total prostate specific antigen in serum. Fernández-Sánchez C; McNeil CJ; Rawson K; Nilsson O; Leung HY; Gnanapragasam V J Immunol Methods; 2005 Dec; 307(1-2):1-12. PubMed ID: 16277989 [TBL] [Abstract][Full Text] [Related]
35. Isolation and characterization of free form prostate specific antigen (f-PSA) in sera of men with prostate cancer. Noldus J; Chen Z; Stamey TA J Urol; 1997 Oct; 158(4):1606-9. PubMed ID: 9302183 [TBL] [Abstract][Full Text] [Related]
36. PSA and other tissue kallikreins for prostate cancer detection. Stephan C; Jung K; Lein M; Diamandis EP Eur J Cancer; 2007 Sep; 43(13):1918-26. PubMed ID: 17689069 [TBL] [Abstract][Full Text] [Related]
37. Fast and novel purification method to obtain the prostate specific antigen (PSA) from human seminal plasma. Acevedo B; Perera Y; Torres E; Pentón D; Ayala M; Gavilondo J Prostate; 2006 Jul; 66(10):1029-36. PubMed ID: 16598740 [TBL] [Abstract][Full Text] [Related]
38. Strategy for sensitive and specific detection of molecular forms of PSA based on 2DE and kinetic analysis: a step towards diagnosis of prostate cancer. Kumar V; Hassan MI; Singh AK; Dey S; Singh TP; Yadav S Clin Chim Acta; 2009 May; 403(1-2):17-22. PubMed ID: 19118539 [TBL] [Abstract][Full Text] [Related]
40. Different molecular forms of uncomplexed prostate specific antigen (PSA) show similar immunoreactivities. Chu LF; Chen Z; Stamey TA J Urol; 1999 Jun; 161(6):2009-12. PubMed ID: 10332491 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]